TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.
Curated by ChEMBL
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.
Curated by ChEMBL
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
![](/img/powered_by_small.gif)